Nucana PLC

Home » Nucana PLC

IPO

Nucana PLC

They are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying our ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines.

Symbol

NCNA

Price Range
$14.00 - $16.00

Anticipated Shares
6,000,000

Anticipated Date
TBD

Underwriters
Citigroup, Jefferies, Cowen

To view the prospectus for Nucana PLC IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253